Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
213 hedge funds and large institutions have $5.2B invested in Loxo Oncology, Inc in 2018 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 67 increasing their positions, 62 reducing their positions, and 10 closing their positions.
560% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 10
54% more call options, than puts
Call options by funds: $50M | Put options by funds: $32.5M
44% more capital invested
Capital invested by funds: $3.61B → $5.2B (+$1.58B)
35% more funds holding
Funds holding: 158 → 213 (+55)
8% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 62
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$88.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$47.7M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$46.3M |
| 4 |
BlackRock
New York
|
+$42.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$306M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$103M |
| 3 |
O
OrbiMed
New York
|
-$60.6M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$46.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$31.8M |
LOXO Hedge Fund Activity: Q2 2018 in Review
213 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2018, worth a combined $5.2B — up 44% from $3.61B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new LOXO positions and 10 closed out — a net gain of 56 holders — while 67 added to existing stakes and 62 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $88.8M. The largest seller was Fidelity Investments, cutting an estimated $306M.
- 213 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2018, up from 158 in Q1 2018.
- Funds reported $5.2B of Loxo Oncology, Inc stock for Q2 2018, up 44% quarter-over-quarter.
- 66 funds opened new Loxo Oncology, Inc positions in Q2 2018 and 10 closed out, a net change of +56 holders.
- The largest Loxo Oncology, Inc buyer in Q2 2018 was Fidelity International, an estimated $88.8M added.
- The largest Loxo Oncology, Inc seller in Q2 2018 was Fidelity Investments, an estimated $306M sold.
Based on aggregated 13F filings for Q2 2018.